A face‐to‐face comparison of the BBB cell models hCMEC/D3 and hBMEC for their applicability to adenoviral expression of transporters

The blood–brain barrier (BBB) is a structure mainly formed by brain capillary endothelial cells (BCEC) whose role is to regulate the exchange of compounds between the blood and the brain. In this process efflux and uptake transporters play a key role. Aim of this study was to compare the two previou...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Journal of neurochemistry Ročník 168; číslo 9; s. 2611 - 2620
Hlavní autori:	Taggi, Valerio, Schäfer, Anima M., Dolce, Asaél, Meyer zu Schwabedissen, Henriette E.
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	England Blackwell Publishing Ltd 01.09.2024
Predmet:	adenoviral expression system Adenoviridae - genetics Blood-brain barrier Blood-Brain Barrier - metabolism Capacitance Cell culture Cell Line Cell lines drug transporters Efflux Electrical junctions Electrical resistivity Endothelial cells Endothelial Cells - metabolism Gene expression hBMEC hCMEC/D3 Humans Membrane permeability Membrane Transport Proteins - genetics Membrane Transport Proteins - metabolism mRNA Permeability Permeability coefficient Protein transport Proteins Tight junctions Transferrin Von Willebrand factor drug transporters hBMEC hCMEC/D3 blood–brain barrier adenoviral expression system
ISSN:	0022-3042, 1471-4159, 1471-4159
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Abstract	The blood–brain barrier (BBB) is a structure mainly formed by brain capillary endothelial cells (BCEC) whose role is to regulate the exchange of compounds between the blood and the brain. In this process efflux and uptake transporters play a key role. Aim of this study was to compare the two previously established cell lines hCMEC/D3 and hBMEC as BBB cell models for the application of an adenoviral system to transiently express OATP2B1 and Pgp. Comparison of hCMEC/D3 and hBMEC mRNA and protein levels of BBB markers showed a unique expression pattern for each cell line. While showing similar expression of the efflux transporter BCRP, transferrin receptor (TFRC) and of the tight junctions proteins Occludin and ZO‐1, hCMEC/D3 displayed higher levels of the endothelial marker PECAM1, VE‐cadherin, Von Willebrand Factor (VWF) and of the efflux transporter Pgp. Moreover, measuring integrity of the monolayer by determining the Trans‐Endothelial Electrical Resistance (TEER), electrical capacitance (CCl), and inulin apparent permeability coefficient (Papp) revealed higher TEER and lower CCl for hBMEC but comparable Papp in the two cell lines. Following adenoviral infection, enhanced OATP2B1 and Pgp expression and functionality could be observed only in hBMEC. Importantly, the adenoviral expression system did not affect expression of BBB markers and permeability in both cell lines. Taken together, our results provide first evidence that hBMEC is an applicable human BBB cell model in which adenoviral infection can be used to transiently express and investigate transporters of interest. hCMEC/D3 and hBMEC are two previously established Blood–Brain Barrier (BBB) cell models. Our study compared the two cell lines for the expression of key markers, tight junctions and transporters of the BBB, revealing different expression patterns in the two cell lines. Furthermore, we assessed the applicability of the two cell lines for transient overexpression of OATP2B1 and Pgp dependent on adenoviral infection, showing increased expression and functionality only in hBMEC. Collectively, our data suggests that hBMEC is a human BBB cell model suitable for transient expression and study of relevant transporters.
AbstractList	The blood-brain barrier (BBB) is a structure mainly formed by brain capillary endothelial cells (BCEC) whose role is to regulate the exchange of compounds between the blood and the brain. In this process efflux and uptake transporters play a key role. Aim of this study was to compare the two previously established cell lines hCMEC/D3 and hBMEC as BBB cell models for the application of an adenoviral system to transiently express OATP2B1 and Pgp. Comparison of hCMEC/D3 and hBMEC mRNA and protein levels of BBB markers showed a unique expression pattern for each cell line. While showing similar expression of the efflux transporter BCRP, transferrin receptor (TFRC) and of the tight junctions proteins Occludin and ZO-1, hCMEC/D3 displayed higher levels of the endothelial marker PECAM1, VE-cadherin, Von Willebrand Factor (VWF) and of the efflux transporter Pgp. Moreover, measuring integrity of the monolayer by determining the Trans-Endothelial Electrical Resistance (TEER), electrical capacitance (C ), and inulin apparent permeability coefficient (P ) revealed higher TEER and lower C for hBMEC but comparable P in the two cell lines. Following adenoviral infection, enhanced OATP2B1 and Pgp expression and functionality could be observed only in hBMEC. Importantly, the adenoviral expression system did not affect expression of BBB markers and permeability in both cell lines. Taken together, our results provide first evidence that hBMEC is an applicable human BBB cell model in which adenoviral infection can be used to transiently express and investigate transporters of interest. The blood–brain barrier (BBB) is a structure mainly formed by brain capillary endothelial cells (BCEC) whose role is to regulate the exchange of compounds between the blood and the brain. In this process efflux and uptake transporters play a key role. Aim of this study was to compare the two previously established cell lines hCMEC/D3 and hBMEC as BBB cell models for the application of an adenoviral system to transiently express OATP2B1 and Pgp. Comparison of hCMEC/D3 and hBMEC mRNA and protein levels of BBB markers showed a unique expression pattern for each cell line. While showing similar expression of the efflux transporter BCRP, transferrin receptor (TFRC) and of the tight junctions proteins Occludin and ZO‐1, hCMEC/D3 displayed higher levels of the endothelial marker PECAM1, VE‐cadherin, Von Willebrand Factor (VWF) and of the efflux transporter Pgp. Moreover, measuring integrity of the monolayer by determining the Trans‐Endothelial Electrical Resistance (TEER), electrical capacitance (CCl), and inulin apparent permeability coefficient (Papp) revealed higher TEER and lower CCl for hBMEC but comparable Papp in the two cell lines. Following adenoviral infection, enhanced OATP2B1 and Pgp expression and functionality could be observed only in hBMEC. Importantly, the adenoviral expression system did not affect expression of BBB markers and permeability in both cell lines. Taken together, our results provide first evidence that hBMEC is an applicable human BBB cell model in which adenoviral infection can be used to transiently express and investigate transporters of interest. The blood–brain barrier (BBB) is a structure mainly formed by brain capillary endothelial cells (BCEC) whose role is to regulate the exchange of compounds between the blood and the brain. In this process efflux and uptake transporters play a key role. Aim of this study was to compare the two previously established cell lines hCMEC/D3 and hBMEC as BBB cell models for the application of an adenoviral system to transiently express OATP2B1 and Pgp. Comparison of hCMEC/D3 and hBMEC mRNA and protein levels of BBB markers showed a unique expression pattern for each cell line. While showing similar expression of the efflux transporter BCRP, transferrin receptor (TFRC) and of the tight junctions proteins Occludin and ZO‐1, hCMEC/D3 displayed higher levels of the endothelial marker PECAM1, VE‐cadherin, Von Willebrand Factor (VWF) and of the efflux transporter Pgp. Moreover, measuring integrity of the monolayer by determining the Trans‐Endothelial Electrical Resistance (TEER), electrical capacitance (C Cl ), and inulin apparent permeability coefficient (P app ) revealed higher TEER and lower C Cl for hBMEC but comparable P app in the two cell lines. Following adenoviral infection, enhanced OATP2B1 and Pgp expression and functionality could be observed only in hBMEC. Importantly, the adenoviral expression system did not affect expression of BBB markers and permeability in both cell lines. Taken together, our results provide first evidence that hBMEC is an applicable human BBB cell model in which adenoviral infection can be used to transiently express and investigate transporters of interest. image The blood-brain barrier (BBB) is a structure mainly formed by brain capillary endothelial cells (BCEC) whose role is to regulate the exchange of compounds between the blood and the brain. In this process efflux and uptake transporters play a key role. Aim of this study was to compare the two previously established cell lines hCMEC/D3 and hBMEC as BBB cell models for the application of an adenoviral system to transiently express OATP2B1 and Pgp. Comparison of hCMEC/D3 and hBMEC mRNA and protein levels of BBB markers showed a unique expression pattern for each cell line. While showing similar expression of the efflux transporter BCRP, transferrin receptor (TFRC) and of the tight junctions proteins Occludin and ZO-1, hCMEC/D3 displayed higher levels of the endothelial marker PECAM1, VE-cadherin, Von Willebrand Factor (VWF) and of the efflux transporter Pgp. Moreover, measuring integrity of the monolayer by determining the Trans-Endothelial Electrical Resistance (TEER), electrical capacitance (CCl), and inulin apparent permeability coefficient (Papp) revealed higher TEER and lower CCl for hBMEC but comparable Papp in the two cell lines. Following adenoviral infection, enhanced OATP2B1 and Pgp expression and functionality could be observed only in hBMEC. Importantly, the adenoviral expression system did not affect expression of BBB markers and permeability in both cell lines. Taken together, our results provide first evidence that hBMEC is an applicable human BBB cell model in which adenoviral infection can be used to transiently express and investigate transporters of interest.The blood-brain barrier (BBB) is a structure mainly formed by brain capillary endothelial cells (BCEC) whose role is to regulate the exchange of compounds between the blood and the brain. In this process efflux and uptake transporters play a key role. Aim of this study was to compare the two previously established cell lines hCMEC/D3 and hBMEC as BBB cell models for the application of an adenoviral system to transiently express OATP2B1 and Pgp. Comparison of hCMEC/D3 and hBMEC mRNA and protein levels of BBB markers showed a unique expression pattern for each cell line. While showing similar expression of the efflux transporter BCRP, transferrin receptor (TFRC) and of the tight junctions proteins Occludin and ZO-1, hCMEC/D3 displayed higher levels of the endothelial marker PECAM1, VE-cadherin, Von Willebrand Factor (VWF) and of the efflux transporter Pgp. Moreover, measuring integrity of the monolayer by determining the Trans-Endothelial Electrical Resistance (TEER), electrical capacitance (CCl), and inulin apparent permeability coefficient (Papp) revealed higher TEER and lower CCl for hBMEC but comparable Papp in the two cell lines. Following adenoviral infection, enhanced OATP2B1 and Pgp expression and functionality could be observed only in hBMEC. Importantly, the adenoviral expression system did not affect expression of BBB markers and permeability in both cell lines. Taken together, our results provide first evidence that hBMEC is an applicable human BBB cell model in which adenoviral infection can be used to transiently express and investigate transporters of interest. The blood–brain barrier (BBB) is a structure mainly formed by brain capillary endothelial cells (BCEC) whose role is to regulate the exchange of compounds between the blood and the brain. In this process efflux and uptake transporters play a key role. Aim of this study was to compare the two previously established cell lines hCMEC/D3 and hBMEC as BBB cell models for the application of an adenoviral system to transiently express OATP2B1 and Pgp. Comparison of hCMEC/D3 and hBMEC mRNA and protein levels of BBB markers showed a unique expression pattern for each cell line. While showing similar expression of the efflux transporter BCRP, transferrin receptor (TFRC) and of the tight junctions proteins Occludin and ZO‐1, hCMEC/D3 displayed higher levels of the endothelial marker PECAM1, VE‐cadherin, Von Willebrand Factor (VWF) and of the efflux transporter Pgp. Moreover, measuring integrity of the monolayer by determining the Trans‐Endothelial Electrical Resistance (TEER), electrical capacitance (CCl), and inulin apparent permeability coefficient (Papp) revealed higher TEER and lower CCl for hBMEC but comparable Papp in the two cell lines. Following adenoviral infection, enhanced OATP2B1 and Pgp expression and functionality could be observed only in hBMEC. Importantly, the adenoviral expression system did not affect expression of BBB markers and permeability in both cell lines. Taken together, our results provide first evidence that hBMEC is an applicable human BBB cell model in which adenoviral infection can be used to transiently express and investigate transporters of interest. hCMEC/D3 and hBMEC are two previously established Blood–Brain Barrier (BBB) cell models. Our study compared the two cell lines for the expression of key markers, tight junctions and transporters of the BBB, revealing different expression patterns in the two cell lines. Furthermore, we assessed the applicability of the two cell lines for transient overexpression of OATP2B1 and Pgp dependent on adenoviral infection, showing increased expression and functionality only in hBMEC. Collectively, our data suggests that hBMEC is a human BBB cell model suitable for transient expression and study of relevant transporters.
Author	Dolce, Asaél Meyer zu Schwabedissen, Henriette E. Taggi, Valerio Schäfer, Anima M.
Author_xml	– sequence: 1 givenname: Valerio orcidid: 0000-0003-0585-3451 surname: Taggi fullname: Taggi, Valerio organization: University of Bas – sequence: 2 givenname: Anima M. orcidid: 0000-0002-3715-8405 surname: Schäfer fullname: Schäfer, Anima M. organization: University of Bas – sequence: 3 givenname: Asaél surname: Dolce fullname: Dolce, Asaél organization: University of Bas – sequence: 4 givenname: Henriette E. surname: Meyer zu Schwabedissen fullname: Meyer zu Schwabedissen, Henriette E. email: h.meyerzuschwabedissen@unibas.ch organization: University of Bas
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/38735840$$D View this record in MEDLINE/PubMed
BookMark	eNp1kb1uFDEUhS2UiGwCBS-ALNGQYrL-nZ8yOwQSFKCB2vJ67mi98tiDPRvYLiUlz8iT4M1umghcXPtK3znyvecUHfngAaFXlFzQfOZrby5oSZl8hmZUVLQQVDZHaEYIYwUngp2g05TWhNBSlPQ5OuF1xWUtyAz9usS9NvDn_vcUctm9sQnDqKNNwePQ42kFeLFYYAPO4SF04BJetZ-u2vk7jrXv8GqRG9yHuENtxHocnTV6aZ2dtngKWHfgw52N2mH4OUZIyR6so_ZpDHGCmF6g4167BC8P9xn69v7qa3td3H75cNNe3haG17UsOq6FLA2pa9pI2hEh616yqiolMbzqGIBooOmJXgpgRAIRfEnrstcN7SoJgp-ht3vfMYbvG0iTGmzazaY9hE1SnEghOKtZmdE3T9B12ESff6c4pUxIUVY8U68P1GY5QKfGaAcdt-pxxxmY7wETQ0oRemXspKe8gzy_dYoStUtR5RTVQ4pZcf5E8Wj6L_bg_sM62P4fVB8_t3vFX48yq2g
CitedBy_id	crossref_primary_10_1002_prp2_70111 crossref_primary_10_1007_s12035_025_04807_7 crossref_primary_10_1002_bdd_70002 crossref_primary_10_1111_jnc_70015
Cites_doi	10.1160/TH09‐10‐0724 10.1021/jm300212s 10.3390/pharmaceutics14071376 10.1016/S0006‐3495(98)77718‐5 10.1111/j.1471‐4159.2008.05730.x 10.1007/s10695‐021‐01015‐7 10.1006/meth.2001.1262 10.3390/pharmaceutics13060834 10.3389/fphar.2018.00354 10.1016/j.clpt.2006.09.010 10.1038/nprot.2007.303 10.1007/s002329900305 10.1007/s00216‐016‐9313‐6 10.1016/s0169‐409x(98)00083‐0 10.1021/acs.molpharmaceut.8b00631 10.1096/fj.04‐3458fje 10.1021/mp900178j 10.1371/journal.pone.0038149 10.1007/s00406‐006‐0664‐4 10.1021/mp400245g 10.1186/s12987‐020‐00212‐5 10.1111/j.1472‐8206.2012.01071.x 10.1128/AAC.02765‐15 10.1021/acs.molpharmaceut.8b01189 10.1021/mp3004308 10.1113/jphysiol.2007.146852 10.1002/jps.23022 10.1016/j.ejpb.2022.02.017 10.1186/2045‐8118‐10‐33 10.1007/978‐1‐4939‐0320‐7_34 10.1186/2045‐8118‐10‐16 10.1002/jps.23575 10.1161/CIRCRESAHA.109.203596 10.1177/0271678X18788769 10.1101/cshperspect.a020412 10.1111/j.1471‐4159.2011.07208.x 10.3390/ijms22073742 10.1111/bph.16205 10.1006/mpat.2000.0406
ContentType	Journal Article
Copyright	2024 The Authors. published by John Wiley & Sons Ltd on behalf of International Society for Neurochemistry. 2024 The Authors. Journal of Neurochemistry published by John Wiley & Sons Ltd on behalf of International Society for Neurochemistry. 2024. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml	– notice: 2024 The Authors. published by John Wiley & Sons Ltd on behalf of International Society for Neurochemistry. – notice: 2024 The Authors. Journal of Neurochemistry published by John Wiley & Sons Ltd on behalf of International Society for Neurochemistry. – notice: 2024. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID	24P AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QR 7TK 7U7 7U9 8FD C1K FR3 H94 P64 7X8
DOI	10.1111/jnc.16125
DatabaseName	Wiley Online Library Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Chemoreception Abstracts Neurosciences Abstracts Toxicology Abstracts Virology and AIDS Abstracts Technology Research Database Environmental Sciences and Pollution Management Engineering Research Database AIDS and Cancer Research Abstracts Biotechnology and BioEngineering Abstracts MEDLINE - Academic
DatabaseTitle	CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Virology and AIDS Abstracts Technology Research Database Toxicology Abstracts AIDS and Cancer Research Abstracts Chemoreception Abstracts Engineering Research Database Neurosciences Abstracts Biotechnology and BioEngineering Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic
DatabaseTitleList	MEDLINE Virology and AIDS Abstracts CrossRef MEDLINE - Academic
Database_xml	– sequence: 1 dbid: 24P name: Wiley Online Library url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Anatomy & Physiology Chemistry
EISSN	1471-4159
EndPage	2620
ExternalDocumentID	38735840 10_1111_jnc_16125 JNC16125
Genre	researchArticle Research Support, Non-U.S. Gov't Journal Article Comparative Study
GrantInformation_xml	– fundername: Swiss 3R Competence Center
GroupedDBID	--- -~X .3N .55 .GA .GJ .Y3 05W 0R~ 10A 1OB 1OC 24P 29L 2WC 31~ 33P 36B 3SF 4.4 41~ 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5RE 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AAHQN AAIPD AAMNL AANHP AANLZ AAONW AASGY AAXRX AAYCA AAYJJ AAZKR ABCQN ABCUV ABEML ABIVO ABLJU ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACFBH ACGFO ACGFS ACGOD ACGOF ACIWK ACMXC ACNCT ACPOU ACPRK ACRPL ACSCC ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZMN AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFPM AFGKR AFPWT AFRAH AFWVQ AFZJQ AHBTC AHEFC AI. AIACR AIAGR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BAWUL BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DC6 DCZOG DIK DPXWK DR2 DRFUL DRMAN DRSTM DU5 E3Z EBS EJD EMOBN ESX EX3 F00 F01 F04 F5P FEDTE FIJ FUBAC FZ0 G-S G.N GAKWD GODZA GX1 H.X HF~ HGLYW HH5 HVGLF HZI HZ~ IH2 IHE IPNFZ IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MVM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OK1 OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 R.K RIWAO RJQFR ROL RX1 SAMSI SUPJJ TEORI TWZ UB1 V8K VH1 W8V W99 WBKPD WIH WIJ WIK WIN WNSPC WOHZO WOW WQJ WRC WUP WXI WXSBR WYISQ X7M XG1 XJT YFH YNH YOC YUY ZGI ZXP ZZTAW ~IA ~KM ~WT AAMMB AAYXX AEFGJ AEYWJ AGHNM AGQPQ AGXDD AGYGG AIDQK AIDYY AIQQE CITATION O8X CGR CUY CVF ECM EIF NPM 7QR 7TK 7U7 7U9 8FD C1K FR3 H94 P64 7X8
ID	FETCH-LOGICAL-c3885-d3a456c0881951d0458f5277650c37d2ee49e9f0ab4e205e043b186fa91d75e43
IEDL.DBID	24P
ISICitedReferencesCount	7
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001219346700001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	0022-3042 1471-4159
IngestDate	Thu Oct 02 11:05:31 EDT 2025 Fri Jul 25 19:36:27 EDT 2025 Mon Jul 21 05:41:18 EDT 2025 Sat Nov 29 06:49:51 EST 2025 Tue Nov 18 21:13:12 EST 2025 Wed Jan 22 17:16:13 EST 2025
IsDoiOpenAccess	true
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	9
Keywords	drug transporters hBMEC hCMEC/D3 blood–brain barrier adenoviral expression system
Language	English
License	Attribution-NonCommercial-NoDerivs 2024 The Authors. Journal of Neurochemistry published by John Wiley & Sons Ltd on behalf of International Society for Neurochemistry.
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c3885-d3a456c0881951d0458f5277650c37d2ee49e9f0ab4e205e043b186fa91d75e43
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23
ORCID	0000-0003-0585-3451 0000-0002-3715-8405
OpenAccessLink	https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fjnc.16125
PMID	38735840
PQID	3112454673
PQPubID	31528
PageCount	10
ParticipantIDs	proquest_miscellaneous_3054432826 proquest_journals_3112454673 pubmed_primary_38735840 crossref_citationtrail_10_1111_jnc_16125 crossref_primary_10_1111_jnc_16125 wiley_primary_10_1111_jnc_16125_JNC16125
PublicationCentury	2000
PublicationDate	September 2024 2024-09-00 20240901
PublicationDateYYYYMMDD	2024-09-01
PublicationDate_xml	– month: 09 year: 2024 text: September 2024
PublicationDecade	2020
PublicationPlace	England
PublicationPlace_xml	– name: England – name: New York
PublicationTitle	Journal of neurochemistry
PublicationTitleAlternate	J Neurochem
PublicationYear	2024
Publisher	Blackwell Publishing Ltd
Publisher_xml	– name: Blackwell Publishing Ltd
References	2021; 47 2022; 173 2012; 101 2021; 22 2011; 117 2010; 106 2016; 408 2020; 17 2019; 16 2008; 107 2013; 102 2008; 586 2014; 28 2015; 7 2012; 55 2001; 25 2024; 181 2006; 256 2021; 13 2010; 65 2018; 9 2006; 80 2005; 19 1997; 160 2013; 10 1999; 36 2022; 14 2009; 102 2016; 60 2007; 2 2012; 7 2014; 1135 1998; 75 2010; 7 2018; 38 2014; 11 2018; 15 2001; 30 e_1_2_9_30_1 e_1_2_9_31_1 e_1_2_9_11_1 e_1_2_9_34_1 e_1_2_9_10_1 e_1_2_9_35_1 e_1_2_9_13_1 e_1_2_9_32_1 e_1_2_9_12_1 e_1_2_9_33_1 e_1_2_9_15_1 e_1_2_9_38_1 e_1_2_9_14_1 e_1_2_9_39_1 e_1_2_9_17_1 e_1_2_9_36_1 e_1_2_9_16_1 e_1_2_9_37_1 e_1_2_9_19_1 e_1_2_9_18_1 e_1_2_9_41_1 e_1_2_9_20_1 e_1_2_9_40_1 e_1_2_9_22_1 e_1_2_9_21_1 e_1_2_9_24_1 e_1_2_9_23_1 e_1_2_9_8_1 e_1_2_9_7_1 e_1_2_9_5_1 e_1_2_9_4_1 e_1_2_9_3_1 e_1_2_9_2_1 Blume L. F. (e_1_2_9_6_1) 2010; 65 e_1_2_9_9_1 e_1_2_9_26_1 e_1_2_9_25_1 e_1_2_9_28_1 e_1_2_9_27_1 e_1_2_9_29_1
References_xml	– volume: 22 start-page: 3742 issue: 7 year: 2021 article-title: Disease‐induced modulation of drug transporters at the blood‐brain barrier level publication-title: International Journal of Molecular Sciences – volume: 408 start-page: 2095 issue: 8 year: 2016 end-page: 2107 article-title: Validation of an immortalized human (hBMEC) in vitro blood‐brain barrier model publication-title: Analytical and Bioanalytical Chemistry – volume: 65 start-page: 19 issue: 1 year: 2010 end-page: 24 article-title: Temperature corrected transepithelial electrical resistance (TEER) measurement to quantify rapid changes in paracellular permeability publication-title: Pharmazie – volume: 1135 start-page: 415 year: 2014 end-page: 437 article-title: In vitro models of the blood‐brain barrier publication-title: Methods in Molecular Biology – volume: 10 start-page: 289 issue: 1 year: 2013 end-page: 296 article-title: Quantitative targeted absolute proteomic analysis of transporters, receptors and junction proteins for validation of human cerebral microvascular endothelial cell line hCMEC/D3 as a human blood‐brain barrier model publication-title: Molecular Pharmaceutics – volume: 16 start-page: 1220 issue: 3 year: 2019 end-page: 1233 article-title: Proteomic quantification of human blood‐brain barrier SLC and ABC transporters in healthy individuals and dementia patients publication-title: Molecular Pharmaceutics – volume: 102 start-page: 1135 issue: 6 year: 2009 end-page: 1143 article-title: Genetic manipulation of endothelial cells by viral vectors publication-title: Thrombosis and Haemostasis – volume: 15 start-page: 5501 issue: 12 year: 2018 end-page: 5513 article-title: Establishment and validation of competitive counterflow as a method to detect substrates of the organic anion transporting polypeptide 2B1 publication-title: Molecular Pharmaceutics – volume: 102 start-page: 3343 issue: 9 year: 2013 end-page: 3355 article-title: Quantitative atlas of blood‐brain barrier transporters, receptors, and tight junction proteins in rats and common marmoset publication-title: Journal of Pharmaceutical Sciences – volume: 101 start-page: 1337 issue: 4 year: 2012 end-page: 1354 article-title: In vitro blood‐brain barrier models: Current and perspective technologies publication-title: Journal of Pharmaceutical Sciences – volume: 17 start-page: 53 issue: 1 year: 2020 article-title: A face‐to‐face comparison of claudin‐5 transduced human brain endothelial (hCMEC/D3) cells with porcine brain endothelial cells as blood‐brain barrier models for drug transport studies publication-title: Fluids and Barriers of the CNS – volume: 36 start-page: 165 issue: 2–3 year: 1999 end-page: 178 article-title: In vitro model for evaluating drug transport across the blood‐brain barrier publication-title: Advanced Drug Delivery Reviews – volume: 75 start-page: 2743 issue: 6 year: 1998 end-page: 2756 article-title: System for dynamic measurements of membrane capacitance in intact epithelial monolayers publication-title: Biophysical Journal – volume: 9 year: 2018 article-title: Neurosteroid transport in the brain: Role of ABC and SLC transporters publication-title: Frontiers in Pharmacology – volume: 160 start-page: 161 issue: 3 year: 1997 end-page: 175 article-title: The P‐glycoprotein efflux pump: How does it transport drugs? publication-title: The Journal of Membrane Biology – volume: 586 start-page: 1937 issue: 7 year: 2008 end-page: 1949 article-title: Differential effects of hydrocortisone and TNFalpha on tight junction proteins in an in vitro model of the human blood‐brain barrier publication-title: The Journal of Physiology – volume: 13 start-page: 834 issue: 6 year: 2021 article-title: Expression and function of organic anion transporting polypeptides in the human brain: Physiological and pharmacological implications publication-title: Pharmaceutics – volume: 117 start-page: 333 issue: 2 year: 2011 end-page: 345 article-title: Quantitative targeted absolute proteomics of human blood‐brain barrier transporters and receptors publication-title: Journal of Neurochemistry – volume: 256 start-page: 294 issue: 5 year: 2006 end-page: 298 article-title: ABC drug transporter at the blood‐brain barrier: Effects on drug metabolism and drug response publication-title: European Archives of Psychiatry and Clinical Neuroscience – volume: 106 start-page: 297 issue: 2 year: 2010 end-page: 306 article-title: Human skeletal muscle drug transporters determine local exposure and toxicity of statins publication-title: Circulation Research – volume: 7 issue: 1 year: 2015 article-title: The blood‐brain barrier publication-title: Cold Spring Harbor Perspectives in Biology – volume: 28 start-page: 65 issue: 1 year: 2014 end-page: 77 article-title: The mitochondrial fluorescent dye rhodamine 123 is a high‐affinity substrate for organic cation transporters (OCTs) 1 and 2 publication-title: Fundamental & Clinical Pharmacology – volume: 7 start-page: 1057 issue: 4 year: 2010 end-page: 1068 article-title: ABC and SLC transporter expression and proton oligopeptide transporter (POT) mediated permeation across the human blood—brain barrier cell line, hCMEC/D3 publication-title: Molecular Pharmaceutics – volume: 38 start-page: 1667 issue: 10 year: 2018 end-page: 1681 article-title: In‐vitro blood‐brain barrier modeling: A review of modern and fast‐advancing technologies publication-title: Journal of Cerebral Blood Flow and Metabolism – volume: 2 start-page: 2111 issue: 9 year: 2007 end-page: 2119 article-title: Determination of drug permeability and prediction of drug absorption in Caco‐2 monolayers publication-title: Nature Protocols – volume: 19 start-page: 1872 issue: 13 year: 2005 end-page: 1874 article-title: Blood‐brain barrier‐specific properties of a human adult brain endothelial cell line publication-title: The FASEB Journal – volume: 30 start-page: 19 issue: 1 year: 2001 end-page: 28 article-title: Bacterial invasion and transcytosis in transfected human brain microvascular endothelial cells publication-title: Microbial Pathogenesis – volume: 10 issue: 1 year: 2013 article-title: Comparative study of four immortalized human brain capillary endothelial cell lines, hCMEC/D3, hBMEC, TY10, and BB19, and optimization of culture conditions, for an in vitro blood‐brain barrier model for drug permeability studies publication-title: Fluids and Barriers of the CNS – volume: 181 start-page: 36 issue: 1 year: 2024 end-page: 53 article-title: Influence of Slco2b1‐knockout and SLCO2B1‐humanization on coproporphyrin I and III levels in rats publication-title: British Journal of Pharmacology – volume: 60 start-page: 3096 issue: 5 year: 2016 end-page: 3105 article-title: Characterization of 22 Antituberculosis drugs for inhibitory interaction potential on organic anionic transporter polypeptide (OATP)‐mediated uptake publication-title: Antimicrobial Agents and Chemotherapy – volume: 14 start-page: 1376 issue: 7 year: 2022 article-title: Transporter regulation in critical protective barriers: Focus on brain and placenta publication-title: Pharmaceutics – volume: 11 start-page: 665 issue: 3 year: 2014 end-page: 672 article-title: Cell‐specific expression of uptake transporters—a potential approach for cardiovascular drug delivery devices publication-title: Molecular Pharmaceutics – volume: 107 start-page: 1358 issue: 5 year: 2008 end-page: 1368 article-title: The human brain endothelial cell line hCMEC/D3 as a human blood‐brain barrier model for drug transport studies publication-title: Journal of Neurochemistry – volume: 25 start-page: 402 issue: 4 year: 2001 end-page: 408 article-title: Analysis of relative gene expression data using real‐time quantitative PCR and the 2(‐Delta C(T)) method publication-title: Methods – volume: 55 start-page: 4740 issue: 10 year: 2012 end-page: 4763 article-title: Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): Influence of protein expression on drug‐drug interactions publication-title: Journal of Medicinal Chemistry – volume: 80 start-page: 607 issue: 6 year: 2006 end-page: 620 article-title: Organic anion transporting polypeptide 2B1 is a high‐affinity transporter for atorvastatin and is expressed in the human heart publication-title: Clinical Pharmacology and Therapeutics – volume: 7 issue: 5 year: 2012 article-title: Transcriptional profiling of human brain endothelial cells reveals key properties crucial for predictive in vitro blood‐brain barrier models publication-title: PLoS One – volume: 10 issue: 1 year: 2013 article-title: The hCMEC/D3 cell line as a model of the human blood brain barrier publication-title: Fluids and Barriers of the CNS – volume: 173 start-page: 12 year: 2022 end-page: 21 article-title: Re‐evaluation of the hCMEC/D3 based in vitro BBB model for ABC transporter studies publication-title: European Journal of Pharmaceutics and Biopharmaceutics – volume: 47 start-page: 1837 issue: 6 year: 2021 end-page: 1849 article-title: Zebrafish (Danio rerio) Oatp2b1 as a functional ortholog of the human OATP2B1 transporter publication-title: Fish Physiology and Biochemistry – ident: e_1_2_9_25_1 doi: 10.1160/TH09‐10‐0724 – ident: e_1_2_9_22_1 doi: 10.1021/jm300212s – ident: e_1_2_9_37_1 doi: 10.3390/pharmaceutics14071376 – ident: e_1_2_9_5_1 doi: 10.1016/S0006‐3495(98)77718‐5 – ident: e_1_2_9_31_1 doi: 10.1111/j.1471‐4159.2008.05730.x – ident: e_1_2_9_11_1 doi: 10.1007/s10695‐021‐01015‐7 – ident: e_1_2_9_26_1 doi: 10.1006/meth.2001.1262 – ident: e_1_2_9_33_1 doi: 10.3390/pharmaceutics13060834 – ident: e_1_2_9_17_1 doi: 10.3389/fphar.2018.00354 – ident: e_1_2_9_18_1 doi: 10.1016/j.clpt.2006.09.010 – ident: e_1_2_9_20_1 doi: 10.1038/nprot.2007.303 – ident: e_1_2_9_34_1 doi: 10.1007/s002329900305 – ident: e_1_2_9_13_1 doi: 10.1007/s00216‐016‐9313‐6 – ident: e_1_2_9_8_1 doi: 10.1016/s0169‐409x(98)00083‐0 – ident: e_1_2_9_32_1 doi: 10.1021/acs.molpharmaceut.8b00631 – ident: e_1_2_9_41_1 doi: 10.1096/fj.04‐3458fje – ident: e_1_2_9_7_1 doi: 10.1021/mp900178j – ident: e_1_2_9_39_1 doi: 10.1371/journal.pone.0038149 – ident: e_1_2_9_12_1 doi: 10.1007/s00406‐006‐0664‐4 – ident: e_1_2_9_27_1 doi: 10.1021/mp400245g – volume: 65 start-page: 19 issue: 1 year: 2010 ident: e_1_2_9_6_1 article-title: Temperature corrected transepithelial electrical resistance (TEER) measurement to quantify rapid changes in paracellular permeability publication-title: Pharmazie – ident: e_1_2_9_16_1 doi: 10.1186/s12987‐020‐00212‐5 – ident: e_1_2_9_21_1 doi: 10.1111/j.1472‐8206.2012.01071.x – ident: e_1_2_9_30_1 doi: 10.1128/AAC.02765‐15 – ident: e_1_2_9_3_1 doi: 10.1021/acs.molpharmaceut.8b01189 – ident: e_1_2_9_29_1 doi: 10.1021/mp3004308 – ident: e_1_2_9_15_1 doi: 10.1113/jphysiol.2007.146852 – ident: e_1_2_9_28_1 doi: 10.1002/jps.23022 – ident: e_1_2_9_4_1 doi: 10.1016/j.ejpb.2022.02.017 – ident: e_1_2_9_14_1 doi: 10.1186/2045‐8118‐10‐33 – ident: e_1_2_9_9_1 doi: 10.1007/978‐1‐4939‐0320‐7_34 – ident: e_1_2_9_40_1 doi: 10.1186/2045‐8118‐10‐16 – ident: e_1_2_9_19_1 doi: 10.1002/jps.23575 – ident: e_1_2_9_24_1 doi: 10.1161/CIRCRESAHA.109.203596 – ident: e_1_2_9_35_1 doi: 10.1177/0271678X18788769 – ident: e_1_2_9_10_1 doi: 10.1101/cshperspect.a020412 – ident: e_1_2_9_38_1 doi: 10.1111/j.1471‐4159.2011.07208.x – ident: e_1_2_9_2_1 doi: 10.3390/ijms22073742 – ident: e_1_2_9_23_1 doi: 10.1111/bph.16205 – ident: e_1_2_9_36_1 doi: 10.1006/mpat.2000.0406
SSID	ssj0016461
Score	2.5070539
Snippet	The blood–brain barrier (BBB) is a structure mainly formed by brain capillary endothelial cells (BCEC) whose role is to regulate the exchange of compounds... The blood-brain barrier (BBB) is a structure mainly formed by brain capillary endothelial cells (BCEC) whose role is to regulate the exchange of compounds...
SourceID	proquest pubmed crossref wiley
SourceType	Aggregation Database Index Database Enrichment Source Publisher
StartPage	2611
SubjectTerms	adenoviral expression system Adenoviridae - genetics Blood-brain barrier Blood-Brain Barrier - metabolism Capacitance Cell culture Cell Line Cell lines drug transporters Efflux Electrical junctions Electrical resistivity Endothelial cells Endothelial Cells - metabolism Gene expression hBMEC hCMEC/D3 Humans Membrane permeability Membrane Transport Proteins - genetics Membrane Transport Proteins - metabolism mRNA Permeability Permeability coefficient Protein transport Proteins Tight junctions Transferrin Von Willebrand factor
Title	A face‐to‐face comparison of the BBB cell models hCMEC/D3 and hBMEC for their applicability to adenoviral expression of transporters
URI	https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fjnc.16125 https://www.ncbi.nlm.nih.gov/pubmed/38735840 https://www.proquest.com/docview/3112454673 https://www.proquest.com/docview/3054432826
Volume	168
WOSCitedRecordID	wos001219346700001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
journalDatabaseRights	– providerCode: PRVWIB databaseName: Wiley Online Library customDbUrl: eissn: 1471-4159 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0016461 issn: 0022-3042 databaseCode: WIN dateStart: 19970101 isFulltext: true titleUrlDefault: https://onlinelibrary.wiley.com providerName: Wiley-Blackwell – providerCode: PRVWIB databaseName: Wiley Online Library Full Collection 2020 customDbUrl: eissn: 1471-4159 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0016461 issn: 0022-3042 databaseCode: DRFUL dateStart: 19970101 isFulltext: true titleUrlDefault: https://onlinelibrary.wiley.com providerName: Wiley-Blackwell
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB6VFoleeLQ8Fko1IIS4RCSxEzvitJt2BQhWFaJib5Hj2CpSm6DNFtEbR478Rn4JY-chKkBC4mLZyiS2PDP2Z89kBuBJKSMmZKKCNMt0wHklg9JUIihjpa1OOJOy9MkmxGIhl8vsaANeDP_CdPEhxgs3pxl-vXYKrsr2VyUn_Ync_nwFtqKISZe3IeZHowkh5Wk0hgon0ezDCnk3nuHVy5vRbwjzMmD1O878xn-N9SZc74EmTjvJuAUbpt6B3WlNh-yzC3yK3vXT36nvwLV8SPu2C9-maJU2P75-XzdUuDrqMVkhNhYJMuJsNkN3548-k06LJ_nbw_z5AUNVV3gyowYSGkZvhsDeSO7dcC9w3aCixa5x3sWnaL70nrjdp8dQ66v2NhzPD9_nL4M-XUOgiaNJUDFFaEzTshURbKucBdYmsRCEATUTVWwMz0xmQ1VyE4eJCTkrI5lalUWVSAxnd2CzbmpzDzDLhEosk5VSksu4yoTVOg0VoU-CKNZM4NnAt0L3scxdSo3TYjzT1LrwMz6BxyPppy6Ax5-I9gbmF70OtwUjKMoT2kjYBB6Nj4kbbnpVbZpzogld_EA6tqYTuNsJzdgLk4IRvAtpsF42_t598XqR-8r9fyd9ANsx4avO3W0PNterc_MQrurP64_tat-rApViKfdh6-Dd_PgNtT68WvwEt5UPDw
linkProvider	Wiley-Blackwell
linkToHtml	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3Nb9UwDLfGQBqXARsfDwYYhBCXirZJm1Ti8l7ZtMFWcRhitypNUg1ptOi9t4nddtyRv5G_BCf9EBMgIXGpUtVtothOfrFdG-BFJSMmZKKCNMt0wLmRQWWNCKpY6VonnElZ-WIToijk0VH2YQXeDP_CdPkhRoOb0wy_XjsFdwbpX7WcFChyG_Q1uM4JaLjCDZ_2itGHkPI0GnOFk2z2eYV8HM_w6tXd6DeIeRWx-i1n59b_DfY2rPdQE6edbNyBFdtswOa0oWP2l3N8iT7401vVN2AtHwq_bcLlFGul7Y-L78uWLq6NeixXiG2NBBpxNpuhs_qjr6WzwOP8YDt__Zahagwez-gGCQ-jd0Rg7yb3gbjnuGxR0XLXuvjiE7Tf-ljc7tNjsvX54i583Nk-zHeDvmBDoImnSWCYIjymaeGKCLgZ54Otk1gIYo5mwsTW8sxmdagqbuMwsSFnVSTTWmWREYnl7B6sNm1jHwBmmVBJzaRRSnIZm0zUWqehIvxJIKW2E3g1MK7UfTZzV1TjpBxPNY0u_YxP4PlI-rVL4fEnoq2B-2WvxYuSERjlCW0lbALPxsfEDTe9qrHtKdGELoMgHVzTCdzvpGbshUnBCOCFNFgvHH_vvnxX5L7x8N9Jn8La7uHBfrm_V7x_BDdjQltd8NsWrC7np_Yx3NBny8-L-ROvFz8BR2QP0A
linkToPdf	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB6VLQIuPFoeCwUGhFAvEUnsJI7EZTfbFY-yqhCVeoscP1SkklS7W0RvHDnyG_kljJ2HqAAJiUvkKJPY8sx4PnsmMwDPKhGxTCQySPNcBZxrEVRGZ0EVS2VVwpkQlS82kS0W4ugoP9iAl_2_MG1-iOHAzWmGX6-dgptTbX_VclKgyBnoS7DJXRGZEWzO3s8P9wcvQsrTaMgWTtLZZRbykTz9yxft0W8g8yJm9UZnfuP_hnsTrndgEyetdNyCDVNvwfakpo32p3N8jj7805-rb8HVoi_9tg3fJmilMj--fl83dHFtVEPBQmwsEmzE6XSK7twffTWdFR4X7_aKFzOGstZ4PKUbJESM3hWBnaPch-Ke47pBSQte4yKMT9B86aJx208P6daXq9twON_7ULwKupINgSKuJoFmkhCZoqUrIuimnRfWJnGWEQ5ULNOxMTw3uQ1lxU0cJibkrIpEamUe6SwxnN2BUd3U5h5gnmcysUxoKQUXsc4zq1QaSkKgBFOsGcNuz7hSdfnMXVmNk3LY19Sq9DM-hqcD6WmbxONPRDs998tOj1clIzjKEzImbAxPhsfEDTe9sjbNGdGELocgbV3TMdxtpWbohYmMEcQLabBeOP7efflmUfjG_X8nfQxXDmbzcv_14u0DuBYT3Gqj33ZgtF6emYdwWX1ef1wtH3WK8RMIFhB5
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+face%E2%80%90to%E2%80%90face+comparison+of+the+BBB+cell+models+hCMEC%2FD3+and+hBMEC+for+their+applicability+to+adenoviral+expression+of+transporters&rft.jtitle=Journal+of+neurochemistry&rft.au=Taggi%2C+Valerio&rft.au=Sch%C3%A4fer%2C+Anima+M&rft.au=Dolce%2C+Asa%C3%A9l&rft.au=Henriette+E+Meyer%C2%A0zu%C2%A0Schwabedissen&rft.date=2024-09-01&rft.pub=Blackwell+Publishing+Ltd&rft.issn=0022-3042&rft.eissn=1471-4159&rft.volume=168&rft.issue=9&rft.spage=2611&rft.epage=2620&rft_id=info:doi/10.1111%2Fjnc.16125&rft.externalDBID=NO_FULL_TEXT
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-3042&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-3042&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-3042&client=summon